Sweet and Spicy Mix 2 oz & 3 oz bags Cashews, Craisins, Honey Roasted Peanuts, Pepper Nuts, Honey Sesame Sticks MANUFACTURED IN A FIRM TH...
⚠ Critical Alert — Stop Using Immediately
This product has been flagged with severe risks (undeclared allergen). Stop using it now and contact the brand or FDA for a refund, repair, or replacement.
FDA Recall Notice
Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-2460-2017.
The firm was notified by the Ohio Department of Agriculture that they failed to declare the following allergens on various labels: Milk (2 and 3 oz. bags), Soy (2 and 3 oz. bags) or Wheat (2 oz. bags).
Corrective Action (per FDA)
Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-2460-2017.
Recall terminated by FDA.
✅ What you should do
- Stop using the product if you own it.
- Check the model number, lot code, or sell-by date against the recall notice above.
- Contact Lja Enterprises or the retailer where you bought it for a refund, replacement, or repair.
- For the most current official instructions, visit the FDA recall page.
- If you've been hurt by this product, report the incident to FDA.
Consumer Contact (per FDA)
Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-2460-2017.
LJA Enterprises
About the U.S. Food and Drug Administration
The FDA regulates drugs, medical devices, food, cosmetics, and tobacco. Adverse event reports and recall notices are the main public safety signal.
Visit FDA.gov →📣 Report a food, supplement, or cosmetic problem to the FDA
If you had a reaction, found contamination, or experienced a labeling problem with this product, report it to the FDA. The agency uses consumer reports to track emerging safety signals and trigger recalls.
Lja Enterprises Recall FAQ
Lja Enterprises is the subject of a food safety report: Sweet and Spicy Mix 2 oz & 3 oz bags Cashews, Craisins, Honey Roasted Peanuts, Pepper Nuts, Honey Sesame Sticks MANUFACTURED IN A FIRM TH.... The notice was published on May 5, 2017 by the U.S. Food and Drug Administration (FDA). Approximately 15 units are potentially affected.